Myomo to Report First Quarter 2018 Results on May 9, 2018
May 03 2018 - 8:00AM
Business Wire
Management to hold a conference call at 4:30
p.m. EDT
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a
commercial stage medical robotics company, today announced that it
will release its financial results for the first quarter 2018 on
Wednesday, May 9, 2018, after the US markets close.
The Company will host a conference call on Wednesday, May 9,
2018 at 4:30 p.m. EDT featuring remarks by Paul R. Gudonis,
Chairman and Chief Executive Officer, and Ralph A. Goldwasser,
Chief Financial Officer. The conference call will be available via
webcast and can be accessed through Myomo’s Investor Relations
page. Please allow extra time prior to the call to visit the site
and download any necessary software to listen to the live
broadcast.
To dial into the conference call, please dial 1-877-270-2148
from the U.S. or 1-412-902-6510 internationally. Please instruct to
be joined into Myomo’s earnings conference call. A replay of the
conference call will be available approximately one hour after
completion of the live conference call at the Investor Relations
page. A dial-in replay of the call will be available until May 23,
2018; please dial 1-877-344-7529 from the U.S. or 1-412-317-0088
internationally and provide the passcode of 10119821.
About MyomoMyomo, Inc. is a commercial stage medical
robotics company that offers expanded mobility for those suffering
from neurological disorders and upper limb paralysis. Myomo
develops and markets the MyoPro product line. MyoPro is a powered
upper limb orthosis designed to support the arm and restore
function to the weakened or paralyzed arms of patients suffering
from CVA stroke, brachial plexus injury, traumatic brain or spinal
cord injury, ALS or other neuromuscular disease or injury. It is
currently the only marketed device that, sensing a patient’s own
EMG signals through non-invasive sensors on the arm, can restore an
individual’s ability to perform activities of daily living,
including feeding themselves, carrying objects and doing household
tasks. Many are able to return to work, live independently and
reduce their cost of care. Myomo is headquartered in Cambridge,
Massachusetts, with sales and clinical professionals across the
U.S. For more information, please visit www.myomo.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180503005137/en/
For Myomo:ir@myomo.comorInvestor Relations:PCG
AdvisoryVivian Cervantes,
646-863-6244vivian@pcgadvisory.comorPublic
Relations:GreenoughRachel Robbins,
617-275-6521rrobbins@greenough.biz
Myomo (AMEX:MYO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Myomo (AMEX:MYO)
Historical Stock Chart
From Sep 2023 to Sep 2024